HemOnc & COVID-19 Session with Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis
In this session, Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis will discuss and debate the special considerations for managing patients with hematological malignancies in the COVID-19 era.
The topics for discussion include the recommendations made in a recent publication they co-authored in Lancet Haematology:
• Reducing nosocomial COVID-19 infections and resource allocation
• Clinical trial participation
• Treating patients with ALL, CML, MPNs, MDS and AML
This session will be made available on-demand on VJHemOnc.com after the event to all those who have registered.
Previous registration necessary?
Simultaneous translation ?
Will it be recorded?
Amer Zeidan, John Mascarenhas, Jan Bewersdorf, Rory Shallis